Abstract
The notion of patient compliance is a significant topic of debate, as by nature it has implications on a broad community of stakeholders including pharmaceutical manufacturers, physicians who prescribe drugs, patients who may or may not decide to comply, as well as national governments that operate under budgetary constraints. Based on data collected from 2921 South Africa respondents, it would appear that in order to increase sample compliance, the various stakeholders in South Africa may need to undertake further research with the male population, young patients, the relatively more educated and middle income groups, as these sub-categories of individuals have less of a tendency to comply with their physicians' instructions when taking drugs.
Get full access to this article
View all access options for this article.
